The Cooper Companies (COO)
(Real Time Quote from BATS)
$106.57 USD
+0.07 (0.07%)
Updated Sep 6, 2024 11:40 AM ET
2-Buy of 5 2
C Value D Growth B Momentum D VGM
Company Summary
The Cooper Companies Inc, based in Pleasanton, CA, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision (CVI) and CooperSurgical (CSI).
CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company’s products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.
This segment has gained from recent progress in ...
Company Summary
The Cooper Companies Inc, based in Pleasanton, CA, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision (CVI) and CooperSurgical (CSI).
CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company’s products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.
This segment has gained from recent progress in optics and lens material to create proprietary lenses that can treat different kinds of visual defects. It specializes not only in toric lenses that correct astigmatism, but also cosmetic lenses that help reset the appearance of the color of the eye, multifocal lenses that correct presbyobia, and other types of lenses such as those managing ocular dryness. Its principal products include disposable toric lenses, planned replacement toric lenses, and spherical lenses.
CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. This strategic business unit has pursued a strategy of consolidation by acquiring critical treatment niches in a fragmented market.
The company reports its sales under three geographical areas — Americas, EMEA and Asia Pacific. During the second quarter of fiscal 2024, Americas (41.4% of total sales) registered sales of $264.4 million, up 9%. Sales in the EMEA (36.1% of total sales) and Asia Pacific (22.5% of total sales) regions increased 13% and declined 1%, respectively, to $237 million and $134.5 million.
FY23 At a Glance
For fiscal 2023, Cooper’s revenues totaled $3.59 billion.
Revenues at CVI totaled $2.42 billion (67.5% of net sales), while that at CSI grossed $1.17 billion (32.5%).
General Information
The Cooper Companies, Inc
6101 Bollinger Canyon Road Suite 500
San Ramon, CA 94583
Phone: 925-460-3600
Fax: 925-460-3649
Email: ir@cooperco.com
Industry | Medical - Dental Supplies |
Sector | Medical |
Fiscal Year End | October |
Last Reported Quarter | 7/31/2024 |
Exp Earnings Date | 12/5/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.98 |
Current Year EPS Consensus Estimate | 3.63 |
Estimated Long-Term EPS Growth Rate | 11.40 |
Exp Earnings Date | 12/5/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 106.50 |
52 Week High | 107.82 |
52 Week Low | 75.94 |
Beta | 0.98 |
20 Day Moving Average | 1,173,457.25 |
Target Price Consensus | 115.54 |
4 Week | 14.40 |
12 Week | 13.06 |
YTD | 12.57 |
4 Week | 10.58 |
12 Week | 11.63 |
YTD | -2.44 |
Shares Outstanding (millions) | 199.16 |
Market Capitalization (millions) | 21,210.07 |
Short Ratio | NA |
Last Split Date | 11/25/2002 |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $NA |
Fundamental Ratios
P/E (F1) | 29.37 |
Trailing 12 Months | 30.19 |
PEG Ratio | 2.57 |
vs. Previous Year | 14.63% |
vs. Previous Quarter | 12.94% |
vs. Previous Year | 7.80% |
vs. Previous Quarter | 6.39% |
Price/Book | 2.68 |
Price/Cash Flow | 20.98 |
Price / Sales | 5.58 |
7/31/24 | 9.08 |
4/30/24 | 8.87 |
1/31/24 | 8.79 |
7/31/24 | 5.88 |
4/30/24 | 5.72 |
1/31/24 | 5.65 |
7/31/24 | 1.99 |
4/30/24 | 1.95 |
1/31/24 | 1.86 |
7/31/24 | Pending Next EPS Report |
4/30/24 | 1.14 |
1/31/24 | 1.08 |
7/31/24 | 18.49 |
4/30/24 | 18.18 |
1/31/24 | 18.07 |
7/31/24 | 9.45 |
4/30/24 | 9.11 |
1/31/24 | 7.93 |
7/31/24 | 13.67 |
4/30/24 | 12.73 |
1/31/24 | 11.20 |
7/31/24 | 39.79 |
4/30/24 | 39.19 |
1/31/24 | 38.72 |
7/31/24 | 1.68 |
4/30/24 | 1.69 |
1/31/24 | 1.71 |
7/31/24 | 0.33 |
4/30/24 | 0.34 |
1/31/24 | 0.35 |
7/31/24 | 24.64 |
4/30/24 | 25.50 |
1/31/24 | 26.16 |